Cargando…

SAT-LB026 Basal-Prandial Insulin versus Basal-Sliding-Scale Insulin in the Management of Hyperglycemia in Non-Critically Ill Hospitalized Patients

Background: Hyperglycemia in hospitalized patients is a common occurrence and is associated with adverse outcomes. Randomized trials indicated that a basal-prandial Insulin regimen (BPI) is preferred over sliding-scale insulin (SSI) alone in hospitalized patients. BPI is now considered a standard of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malkhasyan, Victoria, Maison-Fomotar, Michele, Palakodety, Naga Swathi, Naing, Soe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Diabetes Mellitus and Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551975/ http://dx.doi.org/10.1210/js.2019-SAT-LB026

Ejemplares similares

Predicting the Need for Basal-Bolus Insulin in Hospitalized Patients With Hyperglycemia: Is Sliding Scale Sometimes the Answer?
por: Jankovic, Ivana, et al.
Publicado: (2021)

SUN-LB026 Do CFTR Modulators Treat Cystic Fibrosis-Related Diabetes?
por: Mehfooz, Ayesha, et al.
Publicado: (2019)

Once Weekly Basal Insulin Fc (BIF) is Safe and Efficacious in Patients with Type 2 Diabetes Mellitus (T2DM) Previously Treated With Basal Insulin
por: Frias, Juan Pablo, et al.
Publicado: (2021)

MON-LB026 Critical Illness Associated Fatal Hypoglycemia in a Non-Diabetic Male
por: Toor, Amit, et al.
Publicado: (2019)

Preclinical Characterization of Once Weekly Basal Insulin Fc (BIF)
por: Moyers, Julie S, et al.
Publicado: (2021)

SUN-LB115 Is the Stepping-Down Approach a Better Option Than Multiple Daily Injections in Patients With Chronic Poorly-Controlled Diabetes on Advanced Insulin Therapy?
por: Naing, Soe, et al.
Publicado: (2020)

SAT-LB028 Efficacy and Safety of Pramlintide as an Adjunct to Insulin U500 Therapy in Veterans with Severe Insulin Resistance
por: Oprea, Mihaela, et al.
Publicado: (2019)

SAT-665 A Case of Hyperglycemia in Post Pancreas Transplant Patient-Is It Insulin Deficiency or Insulin Resistance
por: Polavarapu, Preethi, et al.
Publicado: (2020)

Combination Therapy With Premixed & Basal Insulin Analogues in Asian Indians With Type 2 Diabetes
por: Srivastava, Brijendra Kumar, et al.
Publicado: (2021)

SAT-LB116 Extreme Insulin Resistance: The Diagnostic Challenges When Cost Is a Limitation
por: Cavalcante Parr, Nadia Carenina Nunes, et al.
Publicado: (2020)

Reconsidering the Basal Proportion of Insulin Dose: Glycemic and Microvascular Outcomes in Type 1 Diabetes Mellitus
por: Pozos-Varela, Francisco Javier, et al.
Publicado: (2021)

SAT-LB033 Cryptolepine Action on Insulin Resistance in High-Glucose Diet-Fed Caenorhabditis Elegans
por: Young, Ryan, et al.
Publicado: (2019)

SUN-186 Insulin Antibody Associated Severe Insulin Resistance Leading to Uncontrolled Hyperglycemia
por: Amir, Hajira, et al.
Publicado: (2019)

MON-663 Prandial Insulin Dosing Based on Carbohydrate Content Does Not Significantly Improve Glycemic Control in Hospitalized Patients with Diabetes
por: Goel, Heenam, et al.
Publicado: (2020)

MON-LB031 Higher Insulin Degrading Enzyme Levels in Subjects with Metabolic Syndrome
por: Sofer, Yael, et al.
Publicado: (2019)

SUN-LB029 A Case of Gestational Diabetes with Diabetic Ketoacidosis, Insulin Injection Site Reaction and Anti Insulin Antibodies in Pregnancy
por: Hakimian, Stephanie, et al.
Publicado: (2019)

Hyperglycemia Requiring Insulin Among Pediatric Patients Diagnosed With Hemophagocytic Lymphohistiocytosis
por: Schweisberger, Cintya, et al.
Publicado: (2021)

SAT-LB113 Psychosocial Benefits of Using Basal-IQ® Predictive Low Glucose Suspend Technology in a Real-World Setting: Results From Pediatric Patients With Type 1 Diabetes
por: Singh, Harsimran, et al.
Publicado: (2020)

Use of Intranasal Insulin as Neuroprotection From Hyperglycemia in Rat Model of Extremely Preterm Infants
por: Yauch, Lauren McClure, et al.
Publicado: (2021)

MON-LB121 New Onset Insulin Dependent Diabetes Mellitus Secondary to Treatment With Immune Checkpoint Inhibitor
por: Bitat, Syed Rabha
Publicado: (2020)

MON-LB120 MODY3 With Insulin Coding Gene Mutation and Craniofacial Microsomia: A Case Report
por: Cao, Chenxiang, et al.
Publicado: (2020)

MON-LB116 FGF-21 Is A Reliable Marker Of Insulin Resistance Before The Occurrence Of Glucose Intolerance
por: sawah, ahmed, et al.
Publicado: (2020)

MON-LB128 Phosphoinositide 3-Kinase (PI3K) Inhibitor Induced Hyperglycemia With Alpelisib
por: Barsukova, Yuliya, et al.
Publicado: (2020)

Liver-Specific Expression of Constitutively Active G(s)α Leads to Hyperglycemia With Impaired Insulin Secretion
por: Sun, Hui, et al.
Publicado: (2021)

SUN-LB036 Diabetic Ketoacidosis: A Rare Side Effect of Nivolumab Induced Insulin Dependent Diabetes Mellitus
por: Abid, Haisam, et al.
Publicado: (2019)

SUN-LB117 Faster Acting Insulin Aspart in Patients With Gestational Diabetes Mellitus - an Early Experience From India
por: Bhattacharyya, Supratik
Publicado: (2020)

SUN-LB122 Sequential Testing to Assess Insulin Resistance in the Course of Participation in a Diabetes Prevention Program (DPP)
por: McPhaul, Michael John, et al.
Publicado: (2020)

Trajectory of Glycated Hemoglobin Over Time Among Obese Type 2 Diabetes Patients on U-100 Basal-Bolus Insulin Regimen Using Real-World Data
por: Chen, Jieling, et al.
Publicado: (2021)

SUN-LB032 Severe Insulin Resistance and Nephrotic Range Proteinuria Reversed by Pioglitazone in a Patient With Dunnigan Type Lipodystrophy
por: Sharma, Anjul, et al.
Publicado: (2019)

SAT-LB110 Sulfonylurea-Induced Hypoglycemia: To Use Octreotide or Not
por: Romeu, Jose, et al.
Publicado: (2020)

SUN-LB027 Successful Transition from Insulin Injections to Oral Sufonylurea Therapy in Children with Non Autoimmune Type 1 Diabetes (T1D)
por: Begum-Hasan, Jahanara
Publicado: (2019)

SUN-LB024 Elevation in Morning Glucose Level May Be a Signal for the Development of Immune Checkpoint Inhibitor (ICPi) Induced Autoimmune Diabetes Insulin
por: Zhang, Amy, et al.
Publicado: (2019)

MON-LB113 Insulin Resistance in Type 1 Diabetes Managed With Metformin (INTIMET): Rationale and Study Design of a Randomised Placebo-Controlled Trial
por: Snaith, Jennifer R, et al.
Publicado: (2020)

SAT-LB027 Does Diabetes Education Influence Glycosylated Hemoglobin?
por: Bhargava, Pooja, et al.
Publicado: (2019)

SAT-LB127 Regulation of ENaC by Exosomal Lipids in the Diabetic Kidney
por: Tuna, Kubra M, et al.
Publicado: (2020)

SAT-LB118 Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus
por: Arao, Kevin A, et al.
Publicado: (2020)

Basal Versus Sliding-Scale Regular Insulin in Hospitalized Patients With Hyperglycemia During Enteral Nutrition Therapy
por: Umpierrez, Guillermo E.
Publicado: (2009)

SUN-LB126 Real-World Safety and Effectiveness of Insulin Glargine 300 U/ML (Gla-300) in People With Type 2 Diabetes Who Fast During Ramadan
por: Hassanein, Mohamed, et al.
Publicado: (2020)

The Impact of Adding Prandial Insulin to a Basal Based Regimen with Insulin Glargine in Type 2 Diabetic Patients
por: Khamseh, Mohammad Ebrahim, et al.
Publicado: (2021)

SAT-LB124 Phosphatidylcholine Transfer Protein Interacts With PPARδ to Modulate Activity
por: Druzak, Samuel Adam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v0ef6rvi57p5f0kmff4s0f51s0